Banzel and Epilepsy - a phase IV clinical study of FDA data

Summary:

Epilepsy is reported as a side effect among people who take Banzel (rufinamide), especially for people who are male, 2-9 old, also take Epidiolex, and have Seizures.

The phase IV clinical study analyzes which people have Epilepsy when taking Banzel. It is created by eHealthMe based on reports of 1,559 people who have side effects when taking Banzel from the FDA, and is updated regularly.

What is Banzel?

Banzel has active ingredients of rufinamide. It is often used in epilepsy. eHealthMe is studying from 1,590 Banzel users. Check the latest studies of Banzel.

What is Epilepsy?

Epilepsy (common and diverse set of chronic neurological disorders characterized by seizures) is found to be associated with 1,163 drugs and 1,776 conditions by eHealthMe. Check the latest studies of Epilepsy.

On Jul, 08, 2026

1,559 people reported to have side effects when taking Banzel.
Among them, 12 people (0.77%) have Epilepsy.

Among these 12 people:

What is the gender of people who have Epilepsy when taking Banzel? *

female: 30 %
male: 70 %

What is the age of people who have Epilepsy when taking Banzel? *

What are other drugs people take besides Banzel? *

What are other side effects people have besides Epilepsy? *

Encephalopathy (functioning of the brain is affected by some agent or condition): 3 people, 25.00%
Nausea And Vomiting: 3 people, 25.00%
Seizures (abnormal excessive or synchronous neuronal activity in the brain): 3 people, 25.00%
Viral Infection: 2 people, 16.67%
Migraine (headache): 2 people, 16.67%
Memory Loss: 2 people, 16.67%
Irritability: 2 people, 16.67%
Infusion Site Pain: 2 people, 16.67%
Feeling Abnormal: 2 people, 16.67%
Dry Skin: 2 people, 16.67%

What are the existing conditions these people have? *

Seizures (abnormal excessive or synchronous neuronal activity in the brain): 3 people, 25.00%
Psychotic Disorder: 2 people, 16.67%
Infantile Spasms: 2 people, 16.67%
Immunodeficiency: 2 people, 16.67%
Immune System Disorder: 2 people, 16.67%
Hypergammaglobulinaemia (elevated levels of gamma globulin): 2 people, 16.67%
Headache (pain in head): 2 people, 16.67%
Cytogenetic Abnormality: 2 people, 16.67%
Ammonia Increased: 2 people, 16.67%
Affective Disorder (mental disorder): 2 people, 16.67%

* Approximation only. Some reports may have incomplete information.

Do you take Banzel and have Epilepsy?

- Check whether Epilepsy is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Banzel:

Banzel (1,590 reports)

Epilepsy treatments and more:

Epilepsy (129,285 reports)

Browse all side effects of Banzel:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Epilepsy:

Epilepsy (1,163 drugs)

Browse all the conditions that are associated with Epilepsy:

Epilepsy (1,776 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on rufinamide (the active ingredients of Banzel) and Banzel (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.